Neuroscience Investigator Awards

Funding Agency:
New York Stem Cell Foundation

NYSCF is soliciting applications from early career investigators for Innovator awards in neuroscience. The goal of this initiative is to foster truly bold, innovative scientists with the potential to transform the field of neuroscience.

For the 2022 application cycle, applicants are invited to apply from all fields in neuroscience. NYSCF is committed to supporting a broad range of neuroscience research areas representative of the field, taking into account the immense progress and changes in the field in the last decade. To that end, NYSCF especially encourages applications from neuroscientists whose research areas may be under-supported by traditional funding mechanisms and/or underrepresented in the field as a whole.

This career development award provides up to $1.5 million in flexible funding over 5 years. No institutional overhead is provided. NYSCF will accept applications from researchers based at domestic and international accredited non-profit research and academic institutions.

Deadline: Feb. 16, 2022

Agency Website

Eligibility Requirements

To be eligible, candidates must:

  • Have completed one or more of the following degrees: MD, PhD, DPhil
  • Be within 6 years of starting a faculty (professorship) or comparable position on June 1, 2022 (Note: an additional year of eligibility was added as a result of the COVID-19 crisis)
  • Independently supervise a research team as head of group/laboratory
  • Have a publication record containing articles that are innovative and high impact

If an institutional commitment by Duke University or a Duke University institutional signature is required for your application, the application must be reviewed by the Office of Research Administration (for School of Medicine and School of Nursing) or Office of Research Support (Campus Schools and Centers).

Amount

$1,500,000

Funding Type

Award

Eligibility

Junior Faculty

Category

Medical
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

February 16, 2022